Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2007.094011v1, 2007; 10.1373/clinchem.2007.094011
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.094011v1
53/12/2119    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonanno, C.
Right arrow Articles by Makrigiorgos, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonanno, C.
Right arrow Articles by Makrigiorgos, G. M.

Received on June 27, 2007
Accepted on September 26, 2007

Cancer Diagnostics

Methylation-Specific Fluorescent Amplicon Generation, a Novel Real-Time Signal Generation Method for Methylation-Specific PCR

Cinzia Bonanno 1, Erlet Shehi 2, Daniel Adlerstein 2*, G. Mike Makrigiorgos 3

1 University of Milano Bicocca, Milano, Italy
2 DiaSorin SpA, Saluggia (VC), Italy
3 Dana Farber-Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA

* To whom correspondence should be addressed. E-mail: daniel.adlerstein{at}diasorin.it.

Background: Aberrant promoter methylation is a major mechanism for silencing tumor suppressor genes in cancer. Detection of hypermethylation is used as a molecular marker for early cancer diagnosis, as a prognostic index, or to define therapeutic targets for reversion of aberrant methylation. We report on a novel signal generation technology for real-time PCR to detect gene promoter methylation.

Methods: FLAG (fluorescent amplicon generation) is a homogeneous signal generation technology based on the exceptionally thermostable endonuclease PspGI. FLAG provides real-time signal generation during PCR by PspGI-mediated cleavage of quenched fluorophores at the 5' end of double-stranded PCR products. Methylation-specific PCR (MSP) applied on bisulfite-treated DNA was adapted to a real-time format (methylation-specific FLAG; MS-FLAG) for quantifying methylation in the promoter of CDKN2A (p16), GATA5, and RASSF1. We validated MS-FLAG on plasmids and genomic DNA with known methylation status and applied it to detection of methylation in a limited number of clinical samples. We also conducted bisulfite sequencing on these samples.

Results: Real-time PCR results obtained via MS-FLAG agreed with results obtained via conventional, gel-based MSP. The new technology showed high specificity, sensitivity (2–3 plasmid copies), and selectivity (0.0001% of methylated DNA) on control samples. It enabled correct prediction of the methylation status of all 3 gene promoters in 21 lung adenocarcinoma samples, as confirmed by bisulfite sequencing. We also developed a multiplex MS-FLAG assay for GATA5 and RASSF1 promoters.

Conclusion: MS-FLAG provides a new, quantitative, high-throughput method for detecting gene promoter methylation and is a convenient alternative to agarose gel-based MSP for screening methylation. In addition to methylation, FLAG-based real-time signal generation may have broad applications in DNA diagnostics.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. Di Nicola, E. Ghezzi, F. Gillio, F. Zerilli, E. Shehi, D. Maritano, M. Panizzo, F. Bonelli, and D. Adlerstein
Anchor-Based Fluorescent Amplicon Generation Assays (FLAG) for Real-Time Measurement of Human Cytomegalovirus, Epstein-Barr Virus, and Varicella-Zoster Virus Viral Loads
Clin. Chem., November 1, 2008; 54(11): 1900 - 1907.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.